Amylin

3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs
Yahoo/AP
Thu, 04/4/13 - 01:49 pm
Amylin
Bristol-Myers Squibb
layoffs
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Sat, 12/29/12 - 10:38 am
Takeda
Amylin
obesity
weight loss
Takeda writes off its $1B obesity deal with Amylin
Fierce Biotech
Fri, 12/28/12 - 11:59 am
Amylin
Takeda
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
diabetes
Novo Nordisk
Victoza
Merck
Amylin
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Mon, 10/8/12 - 12:53 pm
Eli Lilly
diabetes
Boehringer Ingelheim
Amylin
LY2605541
GLP-1 agonist
SGLT2 inhibitor
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Bristol-Myers Squibb
Novo Nordisk
Amylin
diabetes
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
patents
Bristol-Myers Squibb
Amylin
AstraZeneca
Novo Nordisk
Eli Lilly
Merck
3 Things to Watch in the Pharmaceutical Sector Right Now
Motley Fool
Tue, 09/4/12 - 11:05 am
Amylin
Bristol-Myers Squibb
Arena Pharmaceuticals
Pfizer
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Mon, 08/27/12 - 05:27 pm
Amylin
M&A
Bristol-Myers Squibb
Merck
Eli Lilly
AstraZeneca
diabetes
AstraZeneca buys equal say over Amylin drugs
Reuters
Thu, 08/9/12 - 10:56 am
Amylin
AstraZeneca
diabetes
Bristol-Myers Squibb
Bristol-Myers completes acquisition of Amylin
Yahoo/Fly on the Wall
Thu, 08/9/12 - 10:43 am
M&A
Amylin
Bristol-Myers Squibb
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Mon, 07/16/12 - 12:16 pm
Eli Lilly
Verastem
Celgene
QLT
Amylin
2 Highly Attractive Pharmaceutical Companies Set To Soar
Seeking Alpha
Mon, 07/16/12 - 12:14 pm
Vivus
Pfizer
Arena Pharmaceuticals
Amylin
Abbott Laboratories
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sun, 07/15/12 - 11:30 am
Xoma
Jazz Pharmaceuticals
Pacific Biosciences
Amylin
Corcept Therapeutics
Santarus
Affymetrix
Ariad Pharmaceuticals
Amyris
Sequenom
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
GSK
Amylin
AstraZeneca
Merck
Novartis
Pfizer
Bristol-Myers starts tender offer for Amylin
Reuters
Tue, 07/10/12 - 11:14 am
tender offer
M&A
Amylin
Bristol-Myers Squibb
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk

Pages